Immunome, Inc.

IMNM ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Shares Outstanding

Fiscal Year	Shares Outstanding
FY2019	9.9M
FY2020	30.5M
FY2021	34.6M
FY2022	36.4M
FY2023	59.5M
FY2024	58.6M
FY2025	87.4M
FY2026	113.1M